Pharma Innovation Trade-offs
John discusses the significant trade-offs in funding pharmaceutical innovation, highlighting how it detracts from other critical areas like healthcare services and education. He emphasizes the low return on investment in the current pharma landscape, where incentives often lead to marginal advancements rather than essential breakthroughs. The conversation also touches on the emotional challenges of advocating for long-term policy changes, drawing parallels to the slow yet impactful efforts seen in social justice movements.In this clip
From this podcast
The Peter Attia Drive Podcast
#125 - John Arnold: The most prolific philanthropist you may not have heard of
Related Questions
What topics related to drug prices are discussed in the episode #125 - John Arnold: The most prolific philanthropist you may not have heard of and the clip Health Policy Insights?
Can we fix Pharma's role in healthcare?
What do you think about the pharmaceutical industry in the context of the episode Curing the Trust Problem with Mark Cuban and the clip Drug Pricing Innovation?